Analyst Consensus
- Current Price
- 107.74 $
- Target (Low)
- 121.00 $
- Target (Mean)
- 142.77 $
- Target (High)
- 183.00 $
- Recommendation
- Buy
- Number of Analysts
- 26
Recommendation Distribution
Recommendation Distribution| Strong Buy | 5 |
|---|
| Buy | 13 |
|---|
| Hold | 9 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 12.3%
- Operating Margin
- 22.1%
- Gross Margin
- 45.6%
- Return on Equity (ROE)
- 11.3%
- Return on Assets (ROA)
- 5.9%
- Revenue Growth
- -5.3%
- Earnings Growth
- -20.2%
- Debt/Equity
- 36.14
- Current Ratio
- 1.29
- Beta
- 0.11
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| May 27, 2026 | Mizuho | Outperform → Outperform |
| May 26, 2026 | Barclays | Overweight → Overweight |
| May 22, 2026 | Morgan Stanley | Overweight → Overweight |
| May 1, 2026 | Barclays | Overweight → Overweight |
| Apr 22, 2026 | Scotiabank | Sector Perform → Sector Perform |
| Apr 9, 2026 | Wells Fargo | Overweight → Overweight |